The role of fine particle lactose on the dispersion and deaggregation of salbutamol sulphate in an air stream in vitro

International Journal of Pharmaceutics

Volumn 176, Issue 1, 1998, Pages 99-110

  Zeng, Xian Ming ^a   Martin, Gary Peter ^a   Tee, Seah Kee ^a   Marriott, Christopher ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Deposition; Dispersion; Dry powder inhalers; Lactose; Magnesium stearate; Salbutamol sulphate

Indexed keywords

LACTOCHEM; LACTOSE; MAGNESIUM STEARATE; SALBUTAMOL; UNCLASSIFIED DRUG;

ARTICLE; DISPERSION; DRUG DEGRADATION; DRUG DISPOSITION; DRUG FORMULATION; DRY POWDER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INHALER; PARTICLE SIZE; PRIORITY JOURNAL;

EID: 0031787402     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(98)00300-7     Document Type: Article

References (24)

1. Adjei, A.L., Gupta, P.K., 1997. Dry powder inhalation aerosols. In: Adjei, A.L., Gupta P.K. (Eds.), Inhalation Delivery of Therapeutic Peptides and Proteins. Marcel Dekker, New York, pp. 625-665.
2. British Pharmacopoeia Commission, 1993. Pressurised inhalations: deposition of the emmited dose. British Pharmacopoeia, vol. II. HMSO, London, A194-196.
3. Byron P., Jashnani R., Germain S. Efficiency of aerosolization from dry powder blends of terbutaline sulfate and lactose NF with different particle size distribution. Pharm. Res. 7:1990;S81.
4. French D.L., Edwards D.A., Niven R.W. The influence of formulation on emission, deaggregation and deposition of dry powders for inhalation. J. Aerosol Sci. 27:1996;769-783.
5. Ganderton D. The generation of respirable cloud from coarse powder aggregates. J. Biopharm. Sci. 3:1992;101-105.
6. Ganderton, D., Kassem, N.M., 1992. Dry powder inhalers. In: Ganderton, D., Jones, T. (Eds.), Advances in Pharamaceutical Sciences, vol. 6. Academic Press, London, pp. 165-191.
7. Gonda I. Aerosols for delivery of therapeutic and diagnostic agents to the respiratory tract. CRC Rev. Ther. Drug Carrier Syst. 6:1990;273.
8. Hersey J.A. Ordered mixing: a new concept in powder mixing practice. Powder Technol. 11:1975;41-44.
9. Hickey A.J., Concessio N.M., Van M.M., Platz A.M. Factors influencing the dispersion of dry powders as aerosols. Pharm. Technol. 18:1994;58-82.
10. Jones T.M., Pilpel N. Some physical properties of lactose and magnesia. J. Pharm. Pharmacol. 17:1965;440-448.
11. Kassem, N.M., 1990. Generation of deeply inspirable dry powders, PhD thesis, University of London.
12. Krupp K. Particle adhesion theory and experiment. Adv. Colloid Interface Sci. 2:1967;111-239.
13. Lam K.K., Newton J.M. Influence of particle size on the adhesion behaviour of powders, after application of an initial press-on forces. Powder Technol. 73:1992;117-125.
14. Lucas P., Anderson K., Staniforth J.N. Protein deposition from dry powder inhalers: fine particle multiplets as performance modifiers. Pharm. Res. 15:1998;562-569.
15. Newman S.P., Clarke S.W. Therapeutic aerosols. I. Physical and practical considerations. Thorax. 38:1983;881-886.
16. Rumpf, H., 1977. Particle adhesion, In: Sastra, K.V.S. (Ed.), Agglomeration 77, American Institute of Mining, Metallurgical and Petroleum Engineers, New York, pp. 97-129.
17. Staniforth, J.N., 1996. Improvement in dry powder inhaler performance: surface passivation effects. Proc. Drug Delivery to the Lungs VII (London), pp. 86-89.
18. Steckel H., Müller B.W. In vitro evaluation of dry powder inhalers. II. Influence of carrier particle size and concentration on in vitro deposition. Int. J. Pharm. 154:1997;31-37.
19. Timsina M.P., Martin G.P., Marriott C., Ganderton D., Yianneskis M. Drug delivery to the respiratory tract using dry powder inhalers. Int. J. Pharm. 101:1994;1-13.
20. Visser J. An invited review: Van der Waals' and other cohesive forces affecting powder fluidization. Powder Technol. 58:1989;1-10.
21. Visser J. Particle adhesion and removal: a review. Part. Sci. Technol. 13:1995;169-196.
22. Zeng, X.M., Tee, S.K., Martin, G.P., Marriott, C., 1996a. Effects of mixing procedure and particle size distribution of carrier particles on the deposition of salbutamol sulphate from dry powder inhaler formulations. Proc. Drug Delivery to the Lung VII (London), pp. 40-43.
23. Zeng X.M., Tee S.K., Martin G.P., Marriott C. Improving the delivery efficiency of dry powder inhaler (DPIs) by adding fine carrier particles to powder formulations. Thorax. 51(3):1996;P195.
24. Zimon, A.D., 1982. Adhesion of Dust and Powder, 2nd ed. Consultant Bureau, London.